A New Blueprint for Chronic Disease Care
- Cardio
- 17/10/2025
A peer-reviewed case study published in NEJM Catalyst highlights Cadence's partnership with Providence as a breakthrough in scalable, proactive chronic disease management. The stu
READ MORE
A peer-reviewed case study published in NEJM Catalyst highlights Cadence's partnership with Providence as a breakthrough in scalable, proactive chronic disease management. The stu
READ MORE
A groundbreaking international study led by the University of Zurich has shown that artificial intelligence (AI) can predict patient risk for the most common type of heart attack more accur
READ MORE
Cardiovascular complications may affect as many as 1 in 7 pregnancies, even among individuals without pre-existing heart disease, according to new research published in Circulation . Th
READ MORE
Despite major advances over recent decades, cardiovascular disease (CVD) remains the leading cause of death in the United States and around the world. Recent data suggest that earlier declines i1
READ MORE
A new report from researchers at the Pennington Biomedical Research Center highlights the growing promise of precision medicine to reshape how obesity is prevented, diagnosed, and treated, while1
READ MORE
Food systems are central to the world’s most urgent challenges, from rising chronic diseases and widening inequality to accelerating climate change and biodiversity loss, according to the 20251
READ MORE
Cardiac magnetic resonance imaging (CMR) is gaining traction in the evaluation of pulmonary hypertension (PH) as clinicians seek non-invasive ways to understand pulmonary artery haemodynami
READ MORE
Cardiovascular diseases (CVD) continue to be the leading cause of death worldwide, responsible for one in three deaths, driven by population growth, ageing, and increased exposure to risk factor1
READ MORE
Many people experience psychological distress, such as depression, anxiety, psychosocial stress, or post-traumatic stress disorder (PTSD), after a heart attack. This distress can negatively affe1
READ MORE
Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality and major adverse cardiovascular events compared with no therapy in patients with myocardial infarction (MI1
READ MORE